1396 - Design and Build of the Medicines Manufacturing Innovation Centre (MMIC)
A Modification Notice
by CENTRE FOR PROCESS INNOVATION LIMITED
- Source
- OJEU
- Type
- Contract (Works)
- Duration
- 2 year
- Value
- £24M
- Sector
- CONSTRUCTION
- Published
- 20 May 2022
- Delivery
- To 19 May 2024 (est.)
- Deadline
- n/a
Concepts
Location
Redcar
2 buyers
1 supplier
- Interserve Construction Livingston
Description
CPI require a Principal Contractor to deliver the Design and Build of the Medicines Manufacturing Innovation Centre as described within the ITT and supporting documentation included with this procurement; The design and build contract will be on the basis of a two stage appointment. The first stage will be in accordance with a Pre-Construction Services Agreement and the second stage in accordance with a NEC4 Engineering and Construction Contract Option A, Priced Contract with Activity Schedule for which the Works Information and Site Information are described in the Tender Appendices. Appointment to the second stage will follow successful completion of the first stage. For the avoidance of doubt, delivery of the process equipment operating in the cleanrooms is not part of this scope. However, the detailed design of the cleanrooms must consider the requirements of this process equipment. NB. The award of this contract is NOT conditional on the approval of grant funding which has already been awarded.
Ammendments to Previous Notice
2. Contract value
GBP 18,000,000 24,000,000
Award Detail
| 1 | Interserve Construction (Livingston)
|
CPV Codes
- 45214620 - Research and testing facilities construction work
Indicators
- Contract modified due to unforeseen circumstances.
Legal Justification
MMIC construction costs which have increased beyond the original contract sum. Due to pandemic cost increases, programme delays due to AMIDS development (local council programme), costs and timings have exponentially increased.
Other Information
MMIC construction costs which have increased beyond the original contract award sum. Due to pandemic cost increases, programme delays due to AMIDS development, costs have exponentially increased. (SC Ref:693092)
Reference
- OJEU 272830-2022